raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:480

Kearns-Sayre syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive, Mitochondrial inheritance, Not applicable
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

A rare inborn error of metabolism that is characterized by progressive external ophthalmoplegia (PEO), pigmentary retinitis and an onset before the age of 20 years. Common additional features include deafness, cerebellar ataxia and heart block.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enKearns-Sayre syndrome
frSyndrome de Kearns-Sayre
deKearns-Sayre-Syndrom
esSíndrome de Kearns-Sayre
itSindrome di Kearns-Sayre
nlSyndroom van Kearns-Sayre
ptSíndrome Kearns-Sayre
plZespół Kearnsa i Sayre'a
csKearnsův-Sayreův syndromKearns-Sayreův syndrom
ukСиндром Кернса-Сейра
zhKearns-Sayre综合征
trKearns-Sayre sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM530000Evalidated
ICD-10H49.8NTBTinclusionvalidated
ICD-119C82.0NTBTindexvalidated
MONDO0010787Evalidated
MeSHD007625Evalidated
UMLSC0022541Evalidated
GARD6817Evalidated
MedDRA10048804Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (11):

No children.

Codes that Orphanet moved or referred to this one:

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MT-ATP8Candidate gene tested inNot yet assessedHGNC:7415ENSG00000228253516070mitochondriamitochondrially encoded ATP synthase membrane subunit 8
MT-TL1Candidate gene tested inNot yet assessedHGNC:7490ENSG00000209082590050mitochondriamitochondrially encoded tRNA-Leu (UUA/G) 1
RRM2BDisease-causing germline mutation(s) inAssessedHGNC:17296ENSG000000483926047128q22.3ribonucleotide reductase regulatory TP53 inducible subunit M2B21378381[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0002 / 100 000EuropeValue and classValidated[EXPERT]_17886296[PMID]
Point prevalence1-9 / 1 000 0000.8 / 100 000FinlandValue and classValidated15781811[PMID]
Point prevalence1-9 / 100 0001 / 100 000United KingdomValue and classValidated17886296[PMID]
Prevalence at birth1-9 / 1 000 0000.3 / 100 000IsraelValue and classValidated33239050[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

30 annotations · validated 2024-03-26
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000580Pigmentary retinopathy
HP:0000590Progressive external ophthalmoplegia
HP:0001709Third degree atrioventricular block
Frequent (79-30%)
HP:0000830Anterior hypopituitarism
HP:0001251Ataxia
HP:0003457EMG abnormality
HP:0000365Hearing impairment
HP:0001252Hypotonia
HP:0002922Increased CSF protein concentration
HP:0004622Progressive intervertebral space narrowing
HP:0000508Ptosis
HP:0003200Ragged-red muscle fibers
HP:0001315Reduced tendon reflexes
HP:0003202Skeletal muscle atrophy
Occasional (29-5%)
HP:0001638Cardiomyopathy
HP:0012622Chronic kidney disease
HP:0100543Cognitive impairment
HP:0000823Delayed puberty
HP:0002750Delayed skeletal maturation
HP:0000726Dementia
HP:0000819Diabetes mellitus
HP:0002015Dysphagia
HP:0003546Exercise intolerance
HP:0004374Hemiplegia/hemiparesis
HP:0000829Hypoparathyroidism
HP:0001324Muscle weakness
HP:0000467Neck muscle weakness
HP:0001947Renal tubular acidosis
HP:0004322Short stature
HP:0001337Tremor

Run the differential on the 3 obligate / very frequent terms

Annotation source: 29493966[PMID]_20301382[PMID]

7

Sources for this card